Recruiting
Peripartum Mental Health Cohort Study in Guangzhou
The purpose of this study is to determine the incidence,development trajectory and risk factors of the main peripartum mental health problems as well as explore its adverse outcomes.
ClinicalTrials.gov IDNCT04499066
PhaseNot Applicable
Enrollment3000
SponsorGuangzhou Women and Children's Medical Center
AgeNo minimum reported
SexFEMALE
Conditions studied
Depression, Anxiety
About this study
The purpose of this study is to determine the incidence,development trajectory and risk factors of the main peripartum mental health problems as well as explore its adverse outcomes.
Primary outcomes
- Change of prevalence of maternal prenatal depression (before 20th gestational week, after 33th gestational week and prior to delivery)
- Change of prevalence of maternal postpartum depression in the first year after delivery (6 weeks, 6 months and 1 year after delivery)
Eligibility information
Inclusion Criteria:
1. Pregnant women with \<20 weeks of gestation
2. Pregnant women intended to eventually deliver in Guangzhou Women and Children's Medical Center
3. Permanent residents or families intended to remain in Guangzhou with their child for more than 3 years
Exclusion Criteria:
1. Combined with heart disease, hypertension, diabetes or hyperthyroidism
2. Taking anti-depressants and other treatments for depression
3. Participants was in infection status when the biological samples were collected
Study locations
- Guangzhou Women and Children's Medical Center, Guangzhou, Guangdong 510623 China
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.